Inactive Instrument

News Nissui Pharmaceutical Co., Ltd.

Equities

4550

JP3678100003

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

MiCAN Technologies Inc. announced that it has received ¥50 million in funding from Nissui Pharmaceutical Co., Ltd.	23-03-22	CI
Nissui Pharmaceutical Co., Ltd.(TSE:4550) dropped from S&P Global BMI Index	22-09-19	CI
Tranche Update on Nissui Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 31, 2022.	22-09-06	CI
Tranche Update on Nissui Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 31, 2022.	22-09-06	CI
Nissui Pharmaceutical Co., Ltd.'s Equity Buyback announced on May 31, 2022 has closed with 12,552,248 shares, representing 55.67% for ¥20,861.84	22-09-04	CI
Shimadzu Corporation completed the acquisition of 34.7% stake in Nissui Pharmaceutical Co., Ltd. for ¥13.3 billion.	22-07-27	CI
Nissui Pharmaceutical : Consolidated Financial Results for the Three Months Ended June 30, 2022	22-07-26	PU
Nissui Pharmaceutical Co., Ltd. announces an Equity Buyback for 13,237,063 shares, representing 58.71% for ¥22,000 million.	22-05-31	CI
Shimadzu Corporation made an offer to acquire a 45.9% stake in Nissui Pharmaceutical Co., Ltd. for ¥17.6 billion.	22-05-30	CI
Nissui Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	22-05-30	CI
Ex-dividend day for final dividend	22-03-29	FA
Consolidated Financial Results for the Six Months Ended September 30, 2021	21-10-27	PU
Announcement: Transition of distribution in Europe, Turkey and Africa	21-09-30	PU
Ex-dividend day for interim dividend	21-09-28	FA
Ex-dividend day for final dividend	21-03-29	FA
Nissui Pharmaceutical Co., Ltd. cancelled the acquisition of 10% stake in Nihon Techno Service Co., Ltd. from Takashi Masaki.	21-03-26	CI
Nissui Pharmaceutical : Consolidated Financial Results for the Nine Months Ended December 31, 2020	21-02-18	PU
Zeria Pharmaceutical Co., Ltd. cancelled the agreement to acquire Nissui Pharm Medical Sales Co., Ltd. from Nissui Pharmaceutical Co., Ltd..	21-01-16	CI
Ex-dividend day for interim dividend	20-09-28	FA
Nissui Pharmaceutical Co., Ltd.(TSE:4550) added to S&P Global BMI Index	20-09-21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Nissui Pharmaceutical Co., Ltd.

Equities

4550

JP3678100003

Summary

Filters